Literature DB >> 17375512

Autoimmune polyglandular syndrome, type II.

Barbara A Majeroni1, Parag Patel.   

Abstract

The combination of autoimmune adrenal insufficiency with autoimmune thyroid disease and/or type 1 autoimmune diabetes mellitus defines autoimmune polyglandular syndrome, type II. The conditions may occur in any order, and diagnosis is confounded by the nonspecific nature of the symptoms of adrenal insufficiency and hypothyroidism. The disorder is not common, but consequences can be life threatening when the diagnosis is overlooked. The conditions usually present in midlife, and women are affected more often than men. The cosyntropin test is recommended for diagnosing adrenal insufficiency, which must be present to diagnose this syndrome. Hormone therapy for each condition is similar to treatment that would be provided if the conditions occurred separately, except that treatment for adrenal insufficiency must be given before thyroid therapy is started when the conditions occur together.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17375512

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  12 in total

1.  Polyglandular autoimmune syndrome type 2: diagnosed in the intensive care unit.

Authors:  Yaseen Ali; Nataliya Kozodoy; Taseen Ali
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

Review 2.  Dermatologic manifestations of endocrine disorders.

Authors:  Michael Lause; Alisha Kamboj; Esteban Fernandez Faith
Journal:  Transl Pediatr       Date:  2017-10

3.  Paraneoplastic (non-metastatic) adrenal insufficiency preceded the onset of primary lung cancer by 12 weeks.

Authors:  Ghanshyam Palamaner Subash Shantha; Anita A Kumar; Vijay Jeyachandran; Deepan Rajamanickam; Emmanuel Bhaskar; Vinod K Paniker; Georgi Abraham
Journal:  BMJ Case Rep       Date:  2009-05-25

4.  A Case of Autoimmune Polyglandular Syndrome (APS) Type II with Hypothyroidism, Hypoadrenalism, and Celiac Disease - A Rare Combination.

Authors:  Manoj Lakhotia; Hans Raj Pahadia; Harish Kumar; Jagdish Singh; Sandeep Tak
Journal:  J Clin Diagn Res       Date:  2015-04-01

5.  Autoimmune polyglandular syndrome type 2: A case report.

Authors:  Agyad Bakkour; Mohammed Deeb Zakkor; Lina Taha Khairy; Rostom Horo; Eman Mohammed Sharif Ahmed; Hachem Alhussein
Journal:  Ann Med Surg (Lond)       Date:  2022-05-16

6.  [Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1].

Authors:  Wilgard Hunger-Battefeld; Katharina Fath; Alexandra Mandecka; Michael Kiehntopf; Christof Kloos; Ulrich Alfons Müller; Gunter Wolf
Journal:  Med Klin (Munich)       Date:  2009-04-01

7.  Schmidt's syndrome presenting as a generalised anxiety disorder: a case report.

Authors:  D Anyfantakis; E K Symvoulakis; I Vourliotaki; S Kastanakis
Journal:  J Med Life       Date:  2013-12-25

8.  A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema.

Authors:  Oleksander Prylutskyi; Olga Prylutska; Anatoliy Degonskyi; Kseniia Tkachenko
Journal:  Ethiop J Health Sci       Date:  2016-09

9.  Co-Occurrence of Systemic Lupus Erythematosus and Autoimmune Polyendocrine Syndrome II: Is There a Pathologic Link?

Authors:  Sameen Aamer; Salman Akram; Muhammad Ali Butt; Aimal Shah
Journal:  Cureus       Date:  2020-10-26

10.  Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.

Authors:  Mara Cananzi; Aleixo M Muise; Luca Bosa; Vritika Batura; Davide Colavito; Karoline Fiedler; Paola Gaio; Conghui Guo; Qi Li; Antonio Marzollo; Claudia Mescoli; Ryusuke Nambu; Jie Pan; Giorgio Perilongo; Neil Warner; Shiqi Zhang; Daniel Kotlarz; Christoph Klein; Scott B Snapper; Thomas D Walters; Alberta Leon; Anne M Griffiths
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.